Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TRVI - Trevi Therapeutics, Inc.
-7.91 M
LAST VALUE
-17.51%
2 YEAR CAGR
-365.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR